



ESCIN MITIGATES HYPOXIA MIMICKING NCI-H23 CELLS THROUGH MODULATION OF MMPs, 
HIF-1α AND HIF-2α 
Original Article 
 
PANNEER SELVAM CHERMAKANI1, GANAPASAM SUDHANDIRAN
Cell Biology Laboratory, Department of Biochemistry, University of Madras, Guindy Campus, Chennai 600025, Tamil Nadu, India 
Email: sudhandiran@yahoo.com 
* 
Received: 17 Sep 2020, Revised and Accepted: 19 Oct 2020 
Objective: The objective of the study is to investigate the effect of escin in hypoxia mimicked NCI-H23 cells through the modulation of matrix 
metalloproteinases (MMPs) 2 and 9.  
ABSTRACT 
Methods: In escin-treated NCI-H23 cells, adhesion, migration, and invasion were detected by the adhesion, wound healing, and Boyden chamber 
assays, respectively. The activation of proteinases was detected using zymography assay. The expressions of HIF-1α and HIF-2α were evaluated by 
immunoblot. 
Results: In the present study, it was observed that escin suppressed chemically induced hypoxia condition and stimulated adhesion, migration, and 
invasion of NCI-H23 cells. Gelatin zymography assay showed that escin inhibited CoCl2 induced MMPs-2 and 9 activations in NCI-H23 cells. 
Furthermore, immunoblot analysis revealed that escin treatment decreased the expression of both HIF-1 and 2α in a dose-dependent manner under 
CoCl2 
Conclusion: Taken together, these results indicate that escin inhibits HIFs-α mediated MMPs-2 and 9 expressions, resulting in suppression of lung 
cancer cell invasion that is induced by chemically induced hypoxia condition. Escin is a potential therapeutic agent for clinical use in preventing the 
invasion of human malignant lung tumors. 
induced hypoxia condition.  
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INTRODUCTION 
Natural products from plants have played a central role in the 
treatment of numerous diseases from ancient times to recent days. 
In addition, due to their minimal side effects play an important role 
in developing new drugs [1]. Escin is a saponin derived from the 
Aesculus hippocastanum. Several research studies have evidenced 
that anti-oxidant [2], anti-cancer [3], anti-inflammation [4], anti-
angiogenic properties [5], reverses multidrug resistance [6]. Escin 
has the ability to reduce MDA-MB-231, and KBM-5 cells invasion by 
regulation of invasive genes such as extracellular matrix (ECM) 
degradation enzyme matrix metalloproteinase-9 (MMP-9) [7-9]. 
However, the anti-invasion effect of escin in human lung 
adenocarcinoma NCI-H23 cells (p53 mutant) has not been reported. 
Invasion is an important step in cancer metastasis and causes 
significant mortality in lung cancer patients [10]. Molecular 
mechanisms of malignant cell invasion involve degradation of the 
ECM components, which offers biochemical and mechanical barriers 
to malignant cell movement [11]. Degradation of ECM requires 
MMPs, a group of zinc atom containing endopeptidases that can 
cleave a protein component in the ECM and participate in tissue 
remodeling, angiogenesis, and invasion in both physiological and 
pathological conditions [12-14]. Within the MMPs family, elevated 
levels of gelatinases such as MMPs-2 and 9 play a critical role in 
degrading ECM and cell migration leading to malignant cell invasion 
in many tumor cell lines, including breast, melanoma, and lung [15, 
16]. Various mechanisms regulate the activation of MMPs-2 and 9 in 
cancer, including tumor hypoxia [17]. Under hypoxia, the activation 
of hypoxia-inducible factors (HIFs) such as HIF-1α and 2α regulates 
the numerous target genes that modulate characteristics of 
tumorigenesis, including MMPs-2 and 9 [18-20]. 
Inhibition of MMPs activities can be used as early targets for lung 
cancer metastasis treatment [21]. Previous studies demonstrated 
that inhibition of MMPs-2 and 9 by natural plant-derived 
compounds, which suppresses the invasiveness of lung cancer A549 
cells [22, 23]. Consequently, inhibiting MMPs-2 and 9 activities 
and/or its upstream regulatory pathways may be critical in treating 
malignant tumors, including lung cancer. Therefore, in this study, 
escin was examined for its inhibitory effects of hypoxia mimicked 
condition induced MMPs-2 and 9 activities and cell invasion in NCI-
H23 cells.  
MATERIALS AND METHODS 
Chemicals and reagents 
Fetal bovine serum (FBS), Antibiotic-antimycotic solution were 
purchased from Gibco, California, USA. Dulbecco’s modified eagle 
medium (DMEM), Escin, Cobalt chloride (CoCl2.6H2
Cell culture maintenance and induction of hypoxia 
O), MTT were 
obtained from Sigma Aldrich, ST. Louis, USA. HIF-1α and HIF-2α 
antibodies were procured from Novus biologicals, USA. All other 
reagents were procured from Sisco Research Laboratories, India. 
NCI-H23 cell line was purchased from NCCS, Pune, India. Cells were 
cultured in DMEM containing a 10% FBS, and 1% antibiotic-
antimycotic solution. To mimic hypoxia, NCI-H23 cell line was pre-
incubated with CoCl2. In both normoxia and hypoxia mimicked 
conditions, NCI-H23 cells were grown at 37 °C in a humidified 
atmosphere in the presence of consistent 5% CO2
Treatments 
. 
For the treatment, exponentially growing NCI-H23 cells were 
pretreated with 100 μM CoCl2 
Cell matrix adhesion assay 
for 2 h before escin treatment in a 
regular normoxic incubator. 
Cell matrix adhesion assay was performed using the procedure 
described previously [24]. Escin treated cells were seeded at the 
density of 10×103 cells/well in a collagen-coated 96 well plate. After 
60 min, the unattached cells were carefully removed and washed 
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with sterile 1X PBS. The attached cells were fixed using 4% 
paraformaldehyde for 20 min then staining with 0.4% crystal violet 
solution for 20 min then rinsed with PBS. The attached cells were 
photographed using the inverted microscope (Motic type 101) in 5 
randomly selected fields. Subsequently, quantification of adhesion 
was performed by extracting the crystal violet from each 
experimental group by added into 1 ml of 33% acetic acid for 15 min 
and the optical density (OD) was calculated at 590 nm. Each set of 
experiments was carried out in triplicate. 
Wound healing assay 
A wound-healing assay was performed, as described previously [25]. 
NCI-H23 cells were seeded and grown to reach 80% confluence in 
12 well tissue culture plate. The cell monolayer was scraped in a 
straight line using 200 μl tip and created a scratch (cell-free areas). 
Then, cell debris was washed and incubated in the absence and 
presence of different concentrations of escin and was cultured under 
chemical mimicked hypoxic condition for 24 h, then photographed 
with an inverted microscope. Each experiment was repeated thrice. 
The ability of NCI-H23 cells migration was measured by the rate of 
wound closure using Tscratch software. 
Invasion assay  
The effect of escin on the invasiveness of NCI-H23 cells was 
determined by Boyden chamber assay [26]. Escin treated NCI-H23 
cells were seeded at the density of 1×105
Gelatin zymography 
 in the collagen-coated 
upper chamber of the Boyden chamber (8 μm polycarbonate 
membrane). The bottom compartments of the Boyden chamber 
were filled with a 10% complete medium. After 24 h of incubation, 
the invaded cells were stained with crystal violet for 15 min and 
washed with 1X PBS. The photographs were taken (5 random fields) 
using a Motic inverted microscope. Furthermore, the invaded cells 
were quantified at 590 nm. Three independent experiments were 
carried out. 
Zymography was performed as described previously [27]. NCI-H23 
cells were treated with different concentrations of escin in serum-
free DMEM medium for 24 h, and then collected the conditioned 
medium. Each crude protein samples were mixed with sample buffer 
(without reducing agent) and resolved on a 10% SDS PAGE 
comprising 0.25% gelatin. The gels were run and washed in 
renaturing buffer and developing buffer. Finally, gelatinolytic 
enzymes were observed after staining with Coomassie brilliant blue 
against a blue background and then photographed. 
Western blotting 
Cell lysates from escin treated or untreated NCI-H23 cells were 
extracted in RIPA lysis buffer, separated by 12% SDS PAGE and 
further transferred to polyvinylidene difluoride membranes. The 
membranes were blocked with 5% BSA for 90 min, and probed with 
specific primary antibodies overnight at 4 °C, and then incubated 
with secondary antibody for 60 min at 37 °C. The protein bands 
were visualized in the X-Ray sheet using ECL reagent. 
Statistical analysis 
Statistical analysis was evaluated by the SPSS software. All 
experimental results were expressed as the mean±SD and assessed 
by one-way ANOVA at a significance level of p<0.05. 
RESULTS 
Effect of escin on NCI-H23 cells adhesion under hypoxia 
mimicked condition 
Adhesion of neoplastic cells to the ECM is considered as the main 
event that regulates metastasis [28]. Therefore, cell-matrix adhesion 
assay was used to examine whether escin could affect the ability of 
NCI-H23 cells to bind collagen-coated plates. As shown in fig. 1A and 
B, the adhesive capabilities of NCI-H23 cells under hypoxia 
mimicked condition was increased as compared with the normoxia, 
whereas treatment of different concentrations of escin significantly 
decreased the adhesive capabilities (p<0.05) under hypoxia 
mimicked condition as compared to hypoxia mimicking NCI-H23 
cells. This data indicated that escin treatment inhibits cells adhesion 




Fig. 1: Effect of escin on adhesiveness in NCI-H23 cells under chemically induced hypoxia condition. A) Escin treatment induced the 
inhibition of NCI-H23 cells adhesion on collagen-coated matrix for 60 min. B) The number of adhering NCI-H23 cells was quantified by 
solubilization of dye with 30% acetic acid and absorbance read at 590 nm. *P<0.05 vs Normoxia (N) and #
 
P<0.05 vs Hypoxia (H). Results 
are presented as the mean±SD of three independent experiments 
Effect of escin on NCI-H23 cells migration under hypoxia 
mimicked condition 
The migration effect of escin on NCI-H23 cells under CoCl2 exposed 
condition was evaluated. Cell migration was tracked by wound 
healing assay. In fig. 2A CoCl2 incubated cells were able to heal the 
wounded NCI-H23 monolayer cells faster as compared to normoxia. 
However, escin treated cells under CoCl2 exposed condition 
diminished the healing abilities as compared to CoCl2
Effect of escin on NCI-H23 cells invasion under hypoxia 
mimicked condition 
 exposed NCI-
H23 cells. This data depicts that escin treatment affects NCI-H23 
cells migration abilities. 
In addition to cancer cell migration, the invasion is a vital parameter 
for cancer cells metastatic cascade [29]. To assess the effect of escin 
on NCI-H23 cell invasion under hypoxia mimicked condition, using 
Boyden chamber. As shown in fig. 3A and B CoCl2 exposed NCI-H23 
cells were able to invade freely through the collagen-coated Boyden 
chamber, whereas escin treatment significantly suppressed the 
invasiveness of NCI-H23 cells in a dose-dependent manner (p<0.05) 
as compared to chemically induced hypoxic NCI-H23 cells. This data 
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implies that escin treatment decreased the CoCl2 
 
induced invasion capabilities on NCI-H23 cells in a concentration-dependent manner. 
 
Fig. 2: Effect of escin on CoCl2 induced migration ability in NCI-H23 cells. A) The migratory ability of NCI-H23 cells was assessed by scratch 
wound healing assay for 24 h. Representative wounds images were photographed after scratch 24 h of healing through an inverted 
microscope. B) Quantification of the percentage of the wound closure area. Each bar indicates the mean±SD of three independent 
experiments. *P<0.05 vs Normoxia (N) and #
 
P<0.05 vs Hypoxia (H) 
 
Fig. 3: Effect of escin on hypoxia mimicked condition induced invasiveness in NCI-H23 cells. A) The effect of escin treatment on an 
invasion of NCI-H23 cells was measured using boyden chamber for 24 h. The images were obtained through an inverted microscope. B) 
The number of invading cells was quantified by solubilization of dye with 30% acetic acid and absorbance was read at 590 nm. Data were 
obtained from triplicate experiments. *P<0.05 vs Normoxia (N) and #
 
P<0.05 vs Hypoxia (H) 
Effect of escin on the activation of MMPs in NCI-H23 cells under 
hypoxia mimicked condition 
Several studies have reported that MMPs are capable of mediating 
metastasis [30]. As shown in fig. 4 the chemical mimicked hypoxia 
condition could significantly increase the activation of MMP-2 and 9 
after 24 h of incubation. However, escin treatment decreased both 
MMPs-2 and 9 expressions in NCI-H23 cells under CoCl2
Effect of escin on the expression of HIF-1 and 2α in NCI-H23 
cells under hypoxia mimicked condition 
 exposed 
condition. 
Western blot analysis was performed to examine the effect of escin 
treatment on the expression of HIF-1 and 2α in NCI-H23 cells. Fig. 
5A shows that 100 µM CoCl2 
  
exposed condition increased 
stabilization of both HIF-1 and 2α protein expression at 24 h in NCI-
H23 cells. Whereas, escin treatment decreased the expression of 
both HIF-1 and 2α protein under hypoxia mimicked conditions in a 
concentration-dependent manner. 
 
Fig. 4: Effect of escin on hypoxia mimicked condition induced MMPs-2 and 9 activations in NCI-H23 cells. NCI-H23 cells were pretreated 
with or without 100 μM CoCl2 for 2 h before treated to escin for 24 h. The conditioned media were collected and analyzed by gelatin 
zymography 
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Fig. 5: Effect of escin on the expression of HIF-1 and 2α in NCI-H23 cells under hypoxia mimicked condition. A) HIF-1 and 2α expression were 
analyzed by western blot. B) Bar graph denotes the expression level of HIF-1 and 2α. *P<0.05 vs Normoxia (N) and #
 
P<0.05 vs Hypoxia (H) 
DISCUSSION 
Metastasis is the major hinder for the treatment and primary cause of 
mortality in lung cancer [10], thus inhibiting the ability of malignant 
cell migration and invasion restraint cancer metastasis and improve 
the survival of cancer patients. The interaction between malignant 
cells and hypoxia is crucial for cancer metastasis, and this is achieved 
by a series of steps, including adhesion, migration, and invasion [31, 
32]. These steps are controlled by a complex molecular mechanism 
[29, 33]. The activation of both HIF-1 and 2α is considered to be one of 
the most noteworthy pathways in solid human tumors [34, 35]. 
Evidences suggested that the activation of HIF-α participated in the 
cancer progression, including migration and invasion [36-39]. Several 
research studies indicate that the inhibition of HIFs could 
downregulate the activation of MMPs, which is an upstream regulator 
of MMPs [20, 21, 40]. It is well known that activation of MMPs, which 
degrade the surrounding ECM and basement membranes, play a vital 
role in lung cancer invasion [41]. Therefore, in the present study infer 
that the MMPs, and HIFs may be a targeted treatment to suppress lung 
adenocarcinoma cell adhesion, migration, and invasion. 
CoCl2 has been used as a mimic to induce hypoxia in both in vitro 
and in vivo studies [42-44]. It is believed that CoCl2 stabilizes HIF-α 
by preventing the prolyl hydroxylase enzymes [45-47]. Previous 
studies suggested that overexpression of HIF-1α enhances the 
invasiveness of lung cancer cells through the active MMP-2 [48]. In 
contrast, silencing of HIF-1α prevents glioma cell migration and 
invasion through alteration of MMP-2 and MMP-9 enzymes [49]. In 
addition, CoCl2 is able to enhance tumor cells adhesion, migration, 
and invasion by stimulating MMP-2 and 9 expressions in breast, 
prostate, and lung cancer cells [23, 50, 51]. In the present study, data 
revealed that the CoCl2 
CONCLUSION 
induced the adhesion, migration, and 
invasion abilities were inhibited by escin in NCI-H23 cells. Also, the 
activation of MMP-2 and 9 levels were dramatically reduced 
following escin treatment. Furthermore, protein expression levels of 
HIF-1α and HIF-2α were inhibited following escin treatment. 
Therefore, the current study demonstrated that escin can effectively 
inhibit chemically induced hypoxia-induced NCI-H23 cells adhesion, 
migration, and invasion by suppressing MMPs activities. 
The current study demonstrated that chemically induced hypoxia 
enhanced the NCI-H23 cells invasion via the activation of both HIF-1 
and 2α. Both HIFs, stimulated the activation of MMP-2 and 9, thus 
inducing NCI-H23 cells invasion. However, the effects induced by 
hypoxia in NCI-H23 cells was inhibited by escin treatment. Taken 
together, this data suggests that the administration of escin might be 
a potential anti-metastatic agent for the treatment of lung cancer. 
However, further investigations are needed to clarify the effect of 
escin on in vivo metastasis model.  
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